Lindus Health

Medical Monitor- Hepatobilliary/Pancreatic cancer

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Part TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Clinical ResearchIndustries

Requirements

Candidates should be distinguished specialist clinicians, specifically Gastroenterologists with Oncologic hepatology expertise or Medical Oncologists specializing in GI malignancies. Applicants should possess high agency, a bias for action, and a passion for changing the healthcare industry and new health treatment development. Experience working in a technology-enabled trials delivery company is desired.

Responsibilities

The role involves providing medical monitoring for complex clinical trials and acting as a Subject Matter Expert in hepatobiliary/pancreatic cancer. Responsibilities also include supporting business development activities such as RFP creation and bid defense processes, collaborating directly with the VP of Medical and in-house teams, and providing strategic commercial advisory expertise.

Skills

Gastroenterology
Oncologic Hepatology
Medical Oncology
GI Malignancies
Clinical Trials
Medical Monitoring
Bid Defense
Strategic Advisory

Lindus Health

Accelerates clinical trials for life sciences

About Lindus Health

Lindus Health focuses on speeding up clinical trials to help patients access new treatments more quickly. The company operates differently from traditional contract research organizations (CROs) by using a fixed-price model for studies and milestone-based payments, which aligns their incentives with those of their clients. Lindus Health combines a skilled clinical operations team with a specialized software platform and access to a vast database of 30 million Electronic Health Records. They handle all aspects of clinical studies, including designing the study, recruiting patients, capturing clinical data, monitoring progress, and managing projects. With their approach, Lindus Health has successfully assisted over 90 sponsors in conducting clinical trials across the US, UK, and Europe, completing them up to three times faster than conventional CROs and often delivering results ahead of schedule.

London, United KingdomHeadquarters
2021Year Founded
$23MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Unlimited Paid Time Off
Flexible Work Hours
Mental Health Support
Enhanced Parental Leave
Professional Development Budget
Cycle to work scheme
Stock Options
Regular team events
A new laptop as your main workstation

Risks

AI-driven diagnostics could challenge Lindus Health's market position in clinical trials.
Rapid pathogen evolution in infectious disease trials requires continuous adaptation and innovation.
Demand for diverse patient populations may strain recruitment capabilities in less diverse regions.

Differentiation

Lindus Health accelerates trials using a unique software platform and 30 million EHRs.
They offer fixed-priced quotes and milestone-based payments, aligning incentives with clients.
Their 'All-in-One CRO' solutions cater to specific therapeutic areas like cardiovascular and infectious diseases.

Upsides

Decentralized trials align with Lindus Health's patient-centric approach, enhancing participant reach.
AI integration in trials complements their goal of accelerating clinical trial timelines.
Wearable technology in trials supports continuous monitoring, beneficial for cardiovascular studies.

Land your dream remote job 3x faster with AI